InsidersTradesSigma
Track the 福安药业 stock price and the full management transaction log of the company, a listed issuer based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 福安药业 has logged 2 public disclosures. Market capitalisation: €4.4bn. The latest transaction was reported on 31 January 2023 (Sale). Among the most active insiders: 程靖稀. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
福安药业是一家专注于健康和制药领域的公司。该公司在深圳证券交易所上市。